Finished products, unfinished science: The next phase of supplement validation begins

Despite booming sales, most supplement brands still rely on ingredient-level evidence rather than finished-product validation. This issue examines how that gap in clinical research impacts brand credibility, regulation, and consumer trust — and how innovation in study design and decentralized trials could finally change the equation.

From new approaches at companies like Radicle Science and People Science to insights from leading researchers and brands, NBJ explores the technologies, partnerships, and mindsets shaping the next era of supplement science.

Packed with expert commentary and emerging solutions, the Innovation Science Issue is essential reading for any brand leader, R&D strategist, or investor seeking to strengthen product efficacy claims, navigate FDA scrutiny, and future-proof their innovation pipeline.

Who it’s for: Brand, R&D, and science leaders across the supplement and functional nutrition industry.

What they’ll learn: How decentralized trials, ingredient transparency, and collaborative research models are redefining product validation and competitive advantage in 2025 and beyond.